Primary Cryo

Non-surgical no longer means non-operable

 PrimaryCryo
 primarycryo_large
Primary cryoablation provides a first line therapy for prostate cancer for low, moderate & high-risk disease

What is primary cryo?
  • Primary cryoablation is a first line therapy for low, moderate and high-risk localized prostate cancer.
  • This minimally invasive therapy is an option for high-risk prostate cancer patients who are unable to undergo radical surgery.
Who can benefit from primary cryo?
  • Any Localized Disease
  • Non-Surgical Candidates
  • Low, Moderate and High-Risk Disease
Primary Cryo Applications
These illustrations reflect sample variations of Cryoablation techniques and are not intended for training or educational purposes. Consult the Directions for Use (DFU) for more information.
cryoapp_1

Full gland freeze using 2.4mm cryoprobes

This illustration demonstrates the use of six 2.4mm cryoprobes positioned on both sides of the prostate separated by <2.0cm. A full gland freeze encapsulates the entire prostate with lethal ice (<-40°C). In this illustration the ice balls from the cryoprobes are still forming and will eventually coalesce (typically at 10 minutes).
cryoapp_2

Full freeze beyond the prostate capsule using 2.4mm cryoprobes

This illustration demonstrates the use of six 2.4mm cryoprobes positioned on both sides of the prostate separated by <2.0cm. A full gland freeze encapsulates the entire prostate with lethal ice (<- 40°C). In this illustration the ice balls from the cryoprobes are still forming and will eventually coalesce (typically at 10 minutes). An extra safety margin can be created by extending the ice into the soft tissue beyond the prostate capsule.
cryoapp_3

Full gland freeze using 2.4Smm cryoprobes

This illustration demonstrates the use of six 2.4Smm cryoprobes positioned on both sides of the prostate separated by <2.0cm. A full gland freeze encapsulates the entire prostate with lethal ice (<- 40°C). In this illustration the ice balls from the cryoprobes are still forming and will eventually coalesce (typically at 10 minutes). The 2.4S cryoprobe creates a lethal ice ball 27mm long and is designed for smaller prostate glands.

The Right Probe The Right Outcomes

probe_cryo40
The Cryo-40 is our largest prostate cryoprobe with a diameter of 3.4mm and a length of 23cm. The tip is blunt, requiring the use of our patented FasTrac® introducer and a free-hand (no-grid) approach. At 40mm in diameter and 64mm in length, the teardrop ice ball produces our largest prostate ablation field. Lethal ice (-40°C) is 19mm in diameter and 43mm in length.
probe_cryo44
The Cryo-44 is a Direct AccessTM prostate cryoprobe with a diameter of 2.4mm and a length of 15cm. The tip is trocar shaped, allowing for fast and easy direct access without an introducer. The probe can be used with or without the CryoGridTM and works with our CryoGuide® software to aid probe placement. At 39mm in diameter and 57mm in length, the oval shaped ice ball closely mimics the Cryo-40 isotherm. The lethal ice field of -40°C is 19mm in diameter and 39mm in length.
probe_cryo24
The Cryo-2.4S is a Direct AccessTM prostate cryoprobe with a diameter of 2.4mm and a length of 15cm. The tip is trocar shaped, allowing for fast and easy direct access into the prostate. The probe can be used with or without the CryoGridTM and works with our CryoGuide® software protocols. Probe dimensions are the same as the Cryo-44. The oval shaped ice ball measures 38mm in diameter and 46mm in length; and the lethal isotherm is 19mm in diameter but only 27mm in length, making the 2.4S our shortest of all prostate ice balls.
cryocs_system
The Cryocare CS® combines the latest technology and innovation to make today’s TCAP® procedure simple and fast. Exclusive features of the Cryocare CS include an on-board training module, Integrated Ultrasound designed specifically for the needs of cryosurgical procedures, CryoGuide® intraoperative treatment planning module and AutoFreeze treatment software that simplifies system operation.